0
Clinical Investigations: PROCEDURES |

Role of 99mTc-Hexakis-2-Methoxy-Isobutylisonitrile in the Diagnosis and Staging of Lung Cancer*

Mario Nosotti, MD; Luigi Santambrogio, MD; Massimo Gasparini, MD; Alessandro Baisi, MD; Nadia Bellaviti, MD; Lorenzo Rosso, MD
Author and Funding Information

*From the Department of Thoracic Surgery (Drs. Nosotti, Santambrogio, Baisi, Bellaviti, and Rosso) and the Department of Nuclear Medicine (Dr. Gasparini), IRCCS Ospedale Maggiore Policlinico, Milan, Italy.

Correspondence to: Mario Nosotti, MD, Department of Thoracic Surgery, Padiglione Monteggia, Ospedale Maggiore Policlinico, Via F. Sforsa 35, 20122 Milano, Italy; e-mail: marionosotti@libero.it



Chest. 2002;122(4):1361-1364. doi:10.1378/chest.122.4.1361
Text Size: A A A
Published online

Background: Preliminary studies have shown that 99mTc-hexakis-2-methoxyisobutylisonitrile (MIBI) is an interesting tracer for various tumors. The aim of this study was to determine the feasibility of using 99mTc-MIBI as a diagnostic and staging procedure for lung cancer.

Methods: We prospectively compared the results of biopsy with 99mTc-MIBI imaging in patients with potentially resectable lung lesions (stages IIIA or lower). In the patients with radiopharmaceutical uptake, the staging provided by CT was compared with that obtained with 99mTc-MIBI.

Results: Ninety-nine of the 116 patients examined had lung cancer. For the diagnosis of malignancy, the specificity of 99mTc-MIBI was 100%, sensitivity was 89.8%, positive predictive value was 100%, negative predictive value was 62.9%, and accuracy was 91.4%. In the 87 patients with radiopharmaceutical uptake in their lung cancer, the values for the specificity and sensitivity of 99mTc-MIBI in the detection of mediastinal lymph node metastases were 100% and 54.5%, respectively. The corresponding values for CT in the same patients were 87.6% and 63.3%, respectively. The difference in specificity is statistically significant (p = 0.011).

Conclusions: This study demonstrates that 99mTc-MIBI provides significant diagnostic and staging information in patients with lung lesions. The high specificity and positive predictive value of 99mTc-MIBI suggest that this radiopharmaceutical could be a very useful tool for the diagnosis of lung cancer, especially in consideration of its low costs and wide availability.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543